中国实用内科杂志2018，Vol.38Issue(2)：113-116,122,5.DOI:10.19538/j.nk2018020105
关注慢性髓系白血病的患者报告结局
Focus on the patient-reported outcome of patients with chronic myeloid leukemia
江倩1
作者信息
- 1. 北京大学人民医院北京大学血液病研究所,北京100044
- 折叠
摘要
Abstract
Successful use of tyrosine kinase inhibitors prolongs survival of patients with chronic myeloid leukemia and make it dose to normal population.In clinical practice,there is a lot of important information that can only be learned from the patient.Therefore,integrating patient-reported outcome (PRO) into clinical trial and clinical practice has become one of academic concerns.Definition and research of PRO in CML will be reviewed in this paper.关键词
慢性髓系白血病/患者报告结局/酪氨酸激酶抑制剂Key words
chronic myeloid leukemia/patient-reported outcome/tyrosine-kinase inhibitor分类
医药卫生引用本文复制引用
江倩..关注慢性髓系白血病的患者报告结局[J].中国实用内科杂志,2018,38(2):113-116,122,5.
